ORGANOGENESIS HOLDINGS INC. Restricted Cash, Current
ORGANOGENESIS HOLDINGS INC. (ORGO) had Restricted Cash, Current of $747.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-06
- 2026-06-30: Restricted Cash, Current $747.00K.
- 2026-03-31: Restricted Cash, Current $720.00K.
- 2025-12-31: Restricted Cash, Current $652.00K.
- 2025-09-30: Restricted Cash, Current $627.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $747.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $720.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $652.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $627.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $659.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $569.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $580.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $586.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $575.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $720.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $498.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $599.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $591.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $721.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $812.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $771.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $665.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $605.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $599.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $487.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $517.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $500.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $412.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $374.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $299.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $176.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $196.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $185.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $119.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $102.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $114.00K 10-K · filed 2020-03-09 |
| 2017-12-31 | $49.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |